SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
Open Access
- 5 September 2021
- Vol. 13 (9), 1773
- https://doi.org/10.3390/v13091773
Abstract
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).Keywords
Funding Information
- Indian Council of Medical Research (COVID-19)
This publication has 35 references indexed in Scilit:
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityCell, 2021
- Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters?American Journal of Respiratory Cell and Molecular Biology, 2020
- Test on stool samples improves the diagnosis of hospitalized patients: Detection of SARS-CoV-2 genomic and subgenomic RNAJournal of Infection, 2020
- SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus DiseaseEmerging Infectious Diseases, 2020
- Animal models for COVID-19Nature, 2020
- Pathogenesis and transmission of SARS-CoV-2 in golden hamstersNature, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patientsIndian Journal of Medical Research, 2020
- Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infectionIndian Journal of Medical Research, 2020
- Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in IndiaIndian Journal of Medical Research, 2020